Upcoming DIR Fee Changes Still Causing Concern for Pharmacists
Drug Topics
AUGUST 12, 2023
New DIR fee rules eliminate clawbacks, but may create cashflow challenges for pharmacies in the first half of 2024.
Drug Topics
AUGUST 12, 2023
New DIR fee rules eliminate clawbacks, but may create cashflow challenges for pharmacies in the first half of 2024.
Pharmacy Times
AUGUST 16, 2023
The daily oral formulation of ketamine, KET01, has the potential to greatly improve the standard treatment practices for treatment-resistant depression, according to investigators.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Store News
AUGUST 16, 2023
The company announced that its products have recently launched into 5,000 new locations across several retailers, including Target, Albertsons, CVS, H-E-B, Sprouts and Winn-Dixie.
Fierce Pharma
AUGUST 18, 2023
It was only last spring that Biogen started a | It was only last spring that Biogen started layoffs that eventually shrank the company’s headcount by nearly 900 people last year. Now, a fresh round of job cuts targeting 1,000 positions has kicked off at the struggling drugmaker. At the same time, Biogen is spending $7.3 billion to buy rare disease specialist Reata Pharmaceuticals.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
AUGUST 14, 2023
Illinois Governor JB Pritzker signed into a law a bill prohibiting PBM retaliation against pharmacists who disclose information during government proceedings.
Pharmacy Times
AUGUST 14, 2023
Study authors note that additional research is necessary to confirm findings and identify biological pathways of associations between sweetened beverages and diseases of the liver.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
AUGUST 18, 2023
It was Thanksgiving 2021, and Michael Young was at Target buying a turkey baster. “I’m in the parking lot, and my chest starts to feel like somebody’s sitting on me,” Young recounted. But he didn’t think too much of it and waited until February to tell the doctor about these on-and-off chest pains. “8:30 a.m.
Drug Topics
AUGUST 14, 2023
Generative AI is the fastest growing technology ever, and is anticipated to be adopted faster than the world wide web.
Pharmacy Times
AUGUST 18, 2023
Previous studies have shown promising results with liver or kidney transplants in patients with HIV, but there was a lack of literature regarding heart transplants specifically.
Fierce Healthcare
AUGUST 18, 2023
At-home diagnostics startup Viome Life Sciences snagged $86.5 million in an oversubscribed series C funding round and will roll out its gut microbiome testing kit into 200 CVS stores. | At-home diagnostics startup Viome Life Sciences snagged $86.5 million in an oversubscribed series C funding round and will roll out its gut microbiome testing kit into 200 CVS stores.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
AUGUST 18, 2023
The first time Phillip Durst saw the big A on the chart, he could hardly believe it. It was the first in a series of letters to check his vision in his left eye. “They keep flipping the chart and it keeps getting smaller and smaller, and I keep identifying the letters — that was huge,” said Durst. “It’s like a miracle.
Drug Topics
AUGUST 15, 2023
Only 4% of money for research and development is used to focus on women’s health issues.
Pharmacy Times
AUGUST 18, 2023
Although the rate of people with probable insomnia who discussed their sleep habits with a physician was relatively high, the number of people who went on to seek actual treatment was low.
Fierce Healthcare
AUGUST 18, 2023
It's not a secret that Americans pay far more than people living in other countries for drugs, and those data hold for trendy weight loss and diabetes treatments as demand for these therapies grows | It's not a secret that Americans pay far more than people living in other countries for drugs, and those data hold for trendy weight loss and diabetes treatments like Ozempic and Wegovy.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
AUGUST 18, 2023
“T he Retrievals,” a disturbing podcast from Serial and the New York Times released this summer, painstakingly tells the stories of women who sought fertility treatments at the Yale Fertility Center in 2020. Over the course of five months, women underwent egg retrievals without any pain medication. Although this procedure is typically done under heavy sedation, a nurse at the clinic had replaced fentanyl with saline.
Drug Topics
AUGUST 16, 2023
PXVX0317 has received Fast Track and Breakthrough Therapy designation from the FDA.
Pharmacy Times
AUGUST 17, 2023
The findings of the study demonstrate the need for preventive interventions for all infants in order to reduce the burden of severe illness from respiratory syncytial virus lower respiratory tract infections.
Fierce Pharma
AUGUST 18, 2023
Vexed by plummeting demand for their shots, COVID-19 vaccine producers are anxiously awaiting the fall inoculation season to get a glimpse of the post-pandemic market landscape, which includes a sh | Vexed by plummeting demand for their shots, COVID-19 vaccine producers are anxiously awaiting the fall inoculation season to get a glimpse of the post-pandemic market landscape.
STAT
AUGUST 18, 2023
With its future in doubt, ProMED, the financially strapped infectious diseases surveillance network, has seen waves of support pour in in recent weeks, with universities and other funders seeking to rescue it, according to the president of the committee that oversees it. Both the International Society for Infectious Diseases, which has hosted ProMED since 1999, and its moderators, many of whom went on strike earlier this month to protest plans to put the service behind a paywall, have been in di
Drug Topics
AUGUST 15, 2023
It's an exciting time for policies being made around food as medicine.
Pharmacy Times
AUGUST 17, 2023
The Mylight phase 3 trial confirmed that there was no clinically meaningful differences between aflibercept and its reference biologic, Eylea, for patients with wet macular degeneration.
ISPE
AUGUST 17, 2023
2022 Roger F. Sherwood Article of the Year Award Finalists Announced Trudy Patterson Thu, 08/17/2023 - 11:22 iSpeak Blog iSpeak 2022 Roger F. Sherwood Article of the Year Award Finalists Announced ISPE 17 August 2023 Pharmaceutical Engineering ® is delighted to announce the finalists for the 2022 Roger F. Sherwood Article of the Year Award. The articles were selected by judges of 36 feature and technical articles published in Pharmaceutical Engineering during the 2022 calendar year (Volume 42).
STAT
AUGUST 17, 2023
When someone says the word embryo, what do you think of? Probably that picture you’ve seen a thousand times on a thousand different news articles: a translucent orb swelling with cytoplasm being prodded by a microinjection needle under the light of a microscope. The mainstreaming of IVF, or in vitro fertilization, has familiarized new generations of people with what the earliest stages of human development entails.
Fierce Healthcare
AUGUST 17, 2023
David Entwistle has a storied career as a healthcare executive leading new innovations and steering strategic growth at academic medical centers. | Stanford Health Care CEO David Entwistle joined the board of directors at New York City-based Redesign Health. Here are the areas of healthcare he thinks are ripe for innovation.
Pharmacy Times
AUGUST 16, 2023
Key study finding shows associations between the beat frequency in the rhythmic stimulus in the frontal left sites of infant brains and pathways related to brain modulation and nucleotide levels.
Fierce Pharma
AUGUST 17, 2023
Despite all the upheaval in the pharma industry over the last few years, many familiar names will remain at the top of the industry's sales charts toward the end of the decade. | Merck cancer superstar Keytruda is projected to be the world’s top selling drug by a huge margin in 2028, according to a report by Evaluate. On its list of top 10 drugs by sales in 2028, Keytruda is expected to top the $30 billion mark, with no other therapy predicted to reach $20 billion in sales.
STAT
AUGUST 17, 2023
The health care industry didn’t just provide a safe haven for jittery stock investors in 2022, a year defined by inflation and higher interest rates. It also provided a stable stream of wealth for top executives, who collectively pocketed billions of dollars in what was otherwise a rough patch for the economy. By almost every measure, 2022 was a bad year for the stock market.
Fierce Healthcare
AUGUST 17, 2023
Blue Shield of California today unveiled a new model for pharmacy care that it hopes will overhaul the “broken prescr | Blue Shield of California hopes to cut prescription drugs costs between 10% and 15%, or about $500 million a year, with an ambitious program that sidesteps the pharmacy benefit manager.
Pharmacy Times
AUGUST 16, 2023
Pharmacies brace for a double wave of DIR fees while paddling against profit struggles. Enter Pharmacy AI: a transformative vehicle to navigate stormy waters, enhance efficiency, and prioritize patient care.
Fierce Pharma
AUGUST 17, 2023
As GSK’s ViiV Healthcare looks to widen the reach of its HIV franchise, Médecins Sans Frontières (MSF) has been working to secure access to the company's long-acting HIV prevention drug, Apretude, | The advocacy organization has been trying to lock down supplies of ViiV's long-acting Apretude for more than a year. Now, it's asking the HIV-focused company to remove recently added clauses in the contract that it says derail transparency.
STAT
AUGUST 17, 2023
A South African court ruled the government must disclose contracts signed with pharmaceutical companies for Covid-19 vaccines, a victory for advocates who alleged that authorities may have overpaid for the shots and that the lack of transparency masked pharmaceutical profits at the public’s expense. At issue are contracts signed by the South African government with several companies — including Johnson & Johnson and Pfizer — that provided millions of Covid-19 vaccines du
Fierce Healthcare
AUGUST 17, 2023
A recent survey from eHealth, an independent Medicare insurance adviser, released new data that shows 84% of respondents believe Medicare needs reform, but just 12% think changes should impact thei | A new survey shows that while seniors acknowledge Medicare reform is critical to the program's future, they expect to receive benefits at the cost they were promised.
Pharmacy Times
AUGUST 15, 2023
Through previous literature, investigators found that intervention with nutritional supplements may help to improve cognitive performance and reduce the severity of memory impairment in adults with Alzheimer disease.
Fierce Pharma
AUGUST 17, 2023
Nine states are saying not so fast to a proposed $13.5 million settlement that would get Eli Lilly out of hot water over claims it jacked up the price of its lucrative insulin product Humalog. | In a Tuesday filing in New Jersey Federal Court, lawyers for several states urged U.S. District Judge Brian Martinotti to delay the approval of Lilly's proposed $13.5 million settlement unless it’s altered to make sure states can still file their own insulin pricing lawsuits.
Let's personalize your content